RNAi-mediated β-catenin inhibition impairs tumor growth in multiple immunocompetent CTNNB1-mutated HCC mouse models in advanced-stage disease with lack of response due to expansion of clones derived from secondary driver. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.